JCM Analytics
ActiveSummary
JCM Analytics has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €114,744 and a net result of €96,506. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Equity
- €114,744
- Profit
- €96,506
Why 93raises riskFounded in 2024lowers riskSize: total assets €216,636Liquidity: current ratio 1.98, cash €100,041Equity €114,744 (53.0% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 46% on solvency, 78% on liquidity, 90% on profitability and 99% on growth.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 2 accounts on average 113 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Liquidity more than quadruplescurrent ratio 1.98
- Equity above €100,000equity €114,744 ▲529%
Financials · financial year 2025, micro format
2024 to 2025, 2 financial years
The operating result rises in 2025; 2025 is 7.5 times 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,161 | €21,526 | ▲ 249% |
| Other operating charges640/8 | €597 | €661 | ▲ 10.8% |
| Gross operating margin9900 | €23,549 | €148,123 | ▲ 529% |
| Operating profit (loss)9901 | €16,791 | €125,935 | ▲ 650% |
| Financial income75/76B | - | €22 | - |
| Recurring financial income75 | - | €22 | - |
| Financial charges65/66B | €609 | €1,906 | ▲ 213% |
| Recurring financial charges65 | €609 | €1,906 | ▲ 213% |
| Profit (loss) for the period before taxes9903 | €16,182 | €124,051 | ▲ 667% |
| Income taxes67/77 | €2,943 | €27,546 | ▲ 836% |
| Profit (loss) for the period9904 | €13,239 | €96,506 | ▲ 629% |
| Profit (loss) for the period to be appropriated9905 | €13,239 | €96,506 | ▲ 629% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €117,871 | €216,636 | ▲ 83.8% |
| Fixed assets21/28 | €95,276 | €81,846 | ▼ 14.1% |
| Tangible fixed assets22/27 | €95,276 | €81,846 | ▼ 14.1% |
| Plant, machinery and equipment23 | €15,171 | €13,121 | ▼ 13.5% |
| Furniture and vehicles24 | €67,824 | €57,704 | ▼ 14.9% |
| Other tangible fixed assets26 | €12,280 | €11,021 | ▼ 10.3% |
| Current assets29/58 | €22,595 | €134,790 | ▲ 497% |
| Amounts receivable within one year40/41 | €19,603 | €19,727 | ▲ 0.6% |
| Trade receivables40 | €19,088 | €19,727 | ▲ 3.3% |
| Other amounts receivable41 | €515 | - | - |
| Current investments50/53 | €1,000 | €15,022 | ▲ 15× |
| Cash at bank and in hand54/58 | €1,992 | €100,041 | ▲ 50× |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €117,871 | €216,636 | ▲ 83.8% |
| Equity10/15 | €18,239 | €114,744 | ▲ 529% |
| Contributions10/11 | €5,000 | €5,000 | = |
| Reserves13 | €13,239 | €109,744 | ▲ 729% |
| Distributable reserves133 | €13,239 | €109,744 | ▲ 729% |
| Amounts payable17/49 | €99,632 | €101,892 | ▲ 2.3% |
| Amounts payable after more than one year17 | €49,100 | €33,698 | ▼ 31.4% |
| Financial debts170/4 | €49,100 | €33,698 | ▼ 31.4% |
| Amounts payable within one year42/48 | €50,532 | €68,194 | ▲ 35.0% |
| Current portion of amounts payable after more than one year42 | €16,297 | €15,403 | ▼ 5.5% |
| Trade debts44 | - | €1 | - |
| Suppliers440/4 | - | €1 | - |
| Taxes, remuneration and social security45 | €2,943 | €30,489 | ▲ 936% |
| Taxes450/3 | €2,943 | €30,489 | ▲ 936% |
| Other amounts payable47/48 | €31,292 | €22,302 | ▼ 28.7% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €13,239 | €96,506 | ▲ 629% |
| + Depreciation and write-downs630 | €6,161 | €21,526 | ▲ 249% |
| Operating cash flow (approximation) | €19,400 | €118,032 | ▲ 508% |
| Investment in fixed assets (approximation) | - | -€8,096 | - |
| Change in cash | - | €98,050 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 24-03-2026 | 2026-00060567 |
| 31-12-2024 | micro format | 25-04-2025 | 2025-00075558 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| MERTENS Joachim Constant Maria |
|
Owners and capital
Capital and shareholders
- MERTENS Joachim Constant Maria sole founder · 100% at incorporation
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 01-08-2024 Incorporation · €5,000 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
On 30 July 2024, JCM Analytics was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 MERTENS Joachim Constant Maria has served as director of the company since 2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Acts, filings and financial milestones
01-08
Gazette deed
IncorporationAppointment: MERTENS Joachim Constant Maria (director) · Permanent representative: MERTENS Joachim Constant Maria · Founder9 facts ▸
- Incorporation, “JCM Analytics” (deed in Dutch)
- Founder, MERTENS Joachim Constant Maria
- Other provision, “onder andere, vennootschapsdoel-vermogensvoordeel” (deed in Dutch)
- Founding capital, €5,000
- Other provision, “statutair onbeschikbaar eigen vermogen, inbrengen oprichter en toekomstige inbrengen na oprichting niet geboekt op onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Registered office clause, “2460 Kasterlee,De Meere 3” (deed in Dutch)
- Board rule, 1, “vergadering” (deed in Dutch)
- Director appointment, MERTENS Joachim Constant Maria (director (not named in the articles))
- Permanent representative, MERTENS Joachim Constant Maria (vaste vertegenwoordiger belast met uitvoering opdracht bestuurder en eventueel gedelegeerd bestuurder)
Register details
No listing in the Peppol Directory under this enterprise or VAT number. That proves nothing: being listed there is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance
If you follow this company, Checked tells you the day it appears in the Peppol register.
Register as of 25 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 71363C0983/00D003 | Flanders | 6,874 m² | - | - |
| 13017H0872/00W003 | Flanders | 1,921 m² | 1 · 251 m² | 11.8 m · 3 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het uitoefenen van het beroep van klinisch bioloog,het uitbaten van een laboratorium inzake klinische biologie,de uitoefening van de…” (deed in Dutch)
18 activities (deed in Dutch)
- Het uitoefenen van het beroep van klinisch bioloog,het uitbaten van een laboratorium inzake klinische biologie,de uitoefening van de farmacie op het vlak van de klinische biologie,door de apotheker bioloog vennoot of door andere personen van dezelfde discipline of een aanverwante discipline die in het kader van de vennootschap hun beroep uitoefenen of zullen uitoefenen met dien verstande dat alle medische activiteiten in gemeenschap worden gebracht en alle daaruit voortvloeiende honoraria worden geïnd door en voor de vennootschap.
- De uitbating en beheer van apotheken,overname van deze door alle mogelijke transacties,waaronder fusie,splitsing,aandelenoverdracht,etc.
- Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder die nuttig of nodig zijn voor de uitoefening van voormelde activiteiten.
- De aankoop,het huren en/of leasen van alle medische apparatuur en begeleidende accommodaties,inclusief gebouwen,kortom van een volledige materiële infrastructuur om deze ter beschikking te stellen van een vennoot.
- Het organiseren van lessen,opleidingen,symposia en congressen in verband met de klinische biologie en/of farmacie.
- Het scheppen van de materiële voorwaarden en middelen om dit alles zo degelijk mogelijk te verwezenlijken.
- Alle welk danige verrichtingen die rechtstreeks of onrechtstreeks,geheel of gedeeltelijk betrekking hebben op management en consultancy inzake bovenstaande activiteiten in de meest ruime betekenis van het woord,omvattend-doch geenszins beperkt tot-het uitvoeren van alle studies en onderzoeken alsmede het verlenen van alle adviezen en alle bijstand inzake farmacie en aanverwante bedrijvigheden.
- Het optreden als studie-,organisatie-,raadgevend en beherend bureau inzake de in onderhavig artikel vermelde aangelegenheden,zowel ten behoeve van vennootschappen,ondernemingen,bedrijvigheden,openbare besturen,verenigingen en particulieren.
- Het verrichten van alle handelingen van roerende en onroerende aard,in de meest ruime zin,dit omvat het aankopen en verkopen,het huren,het verhuren,het onderhuren,het bouwen en verbouwen,het in vruchtgebruik of naakte eigendom nemen,het uitrusten en valoriseren en het uitbaten onder alle vormen van alle roerende en onroerende goederen.
- Het besturen van vennootschappen,ongeacht hun voorwerp,het deelnemen in het directie voeren over ondernemingen,vennootschappen en andere rechtspersonen.
- Het bevorderen van de oprichting van vennootschappen door inbreng,participaties of investering.
- Het toestaan van leningen en kredieten aan vennootschappen of particulieren onder om het even welke vorm.Dit alles binnen de perken van de wet.
- Het beleggen of investeren van haar middelen,zelfs gefinancierd door leningen.
- Alle handelingen van commerciële,financiële,van roerende en onroerende aard doen,in zoverre zij niet strijdig zijn met de medische plichtenleer of ethiek
- Alle werkzaamheden en rechtshandelingen verrichten die van aard zijn rechtstreeks of onrechtstreeks de verwezenlijking van haar voorwerp te bevorderen
- Deelnemen aan en samenwerken met alle ondernemingen die een gelijkaardig voorwerp nastreven
- Onder gelijk welke vorm belangen nemen in vennootschappen,verenigingen of ondernemingen die een voorwerp hebben dat gelijkaardig of verwant is aan het hare of dat van aard is om er de verwezenlijking van te vergemakkelijken of te ontwikkelen
- Als bestuurder of vereffenaar van andere vennootschappen of verenigingen optreden
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- JCM Analytics
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, bestuursorgaan mag administratieve zetels,agentschappen,werkhuizen,stapelplaatsen,bijkantoren vestigen in België of…” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Bepaalde of onbepaalde termijn,zonder bepaling onbepaalde duur, 1” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Friday of June at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, elk moment” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Documenten vermelden vennootschap in vereffening, bestuurder(s) in functie krachtens statuten indien geen andere benoemd” (deed in Dutch)